Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 Aug 17;11(1):16655.
doi: 10.1038/s41598-021-95591-6.

A meta-analysis on the prevalence and characteristics of severe malaria in patients with Plasmodium spp. and HIV co-infection

Affiliations
Meta-Analysis

A meta-analysis on the prevalence and characteristics of severe malaria in patients with Plasmodium spp. and HIV co-infection

Aongart Mahittikorn et al. Sci Rep. .

Abstract

Co-infection with malaria and human immunodeficiency virus (HIV) increases the severity and mortality rates of both diseases. A better understanding of the effects of co-infections could help in the diagnosis, prompt treatment, prevention, and control of malarial parasites among HIV-infected patients. In this systematic review and meta-analysis, we estimated the prevalence and characteristics of severe malaria (SM) caused by co-infection with HIV. We included relevant studies that were conducted between the years 1991 and 2018 and reporting on SM. We pooled the prevalence of SM in patients with co-infection, pooled odds ratios of SM in patients with co-infection and Plasmodium mono-infection, and differences in laboratory parameters such as parasite density and leucocyte counts, between co-infected and Plasmodium mono-infected patients. The meta-analysis included 29 studies (1126 SM cases). The pooled prevalence of SM in co-infected patients using the data of 23 studies (SM = 795 cases, all co-infection cases = 2534 cases) was 43.0% (95% confidence interval [CI] 31.0-56.0%; I2, 98.0%). Overall, the odds of SM from 18 studies were pooled. The odds of SM were significantly higher in co-infected patients than in Plasmodium mono-infected patients (OR 2.41; 95% CI 1.43-4.08; I2 = 85%; P = 0.001) and also significantly higher in children (OR 9.69; 95% CI 5.14-18.3; I2, 0%; P < 0.0001; two studies) than in adults (OR 2.68; 95% CI 1.52-4.73; I2, 79.0%; P = 0.0007; 12 studies). Co-infected patients with SM had a higher parasite density than those with Plasmodium mono-infection when the data of seven studies were analysed (SMD, 1.25; 95% CI 0.14-2.36; I2, 98.0%; P = 0.03) and higher leukocyte counts when the data of four studies were analysed (MD, 1570 cells/µL; 95% CI 850-2300 cells/µL; I2, 21.0%; P < 0.0001). Thus, the prevalence of SM among patients co-infected with Plasmodium spp. and HIV is high. Because co-infections could lead to SM, patients with Plasmodium spp. and HIV co-infection should be identified and treated to reduce the prevalence of SM and the number of deaths.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
PRISMA diagram. Flowchart for study selection.
Figure 2
Figure 2
The pooled prevalence estimate of severe malaria in Plasmodium spp. and HIV co-infected patients.
Figure 3
Figure 3
The risk of severe malaria in Plasmodium spp. and HIV co-infected patients.
Figure 4
Figure 4
The pooled MD of parasite density between Plasmodium spp. and HIV co-infected and Plasmodium spp. patients.
Figure 5
Figure 5
The pooled MD of total leukocyte between Plasmodium spp. and HIV co-infected and Plasmodium spp. patients.
Figure 6
Figure 6
The pooled MD of neutrophil counts between Plasmodium spp. and HIV co-infected and Plasmodium spp. patients.
Figure 7
Figure 7
The pooled MD of lymphocyte counts between Plasmodium spp. and HIV co-infected and Plasmodium spp. patients.
Figure 8
Figure 8
The funnel plot demonstrating publication bias across the included studies.
Figure 9
Figure 9
The funnel plot after trim-and-fill method was performed.

References

    1. WHO. World Malaria Report 2019 (2019). https://www.who.int/publications-detail/world-malaria-report-2019. Accessed 25 July 2020.
    1. Berg A, et al. Increased severity and mortality in adults co-infected with malaria and HIV in Maputo, Mozambique: A prospective cross-sectional study. PLoS ONE. 2014;9:e88257. doi: 10.1371/journal.pone.0088257. - DOI - PMC - PubMed
    1. WHO. Malaria in HIV/AIDS Patients (2017). http://www10.who.int/malaria/areas/high_risk_groups/hiv_aids_patients/en/. Accessed 25 July 2020.
    1. WHO. (2019). HIV/AIDS. Available from https://www.who.int/news-room/fact-sheets/detail/hiv-aids Accessed 31 June 2020.
    1. WHO Severe malaria. Trop. Med. Int. Health. 2014;19:7–131. doi: 10.1111/tmi.12313_2. - DOI - PubMed